Results 171 to 180 of about 17,459 (201)
Some of the next articles are maybe not open access.
Invasive meningococcal disease in Spain 2023
Introduction: Description of the epidemiological analysis of invasive meningococcal disease (IMD) in Spain during 2023 and its comparison with previous years. Methods: Descriptive epidemiological analysis of cases of IMD reported to the National Epidemiological Surveillance Network (RENAVE) in 2023 was conducted.Soler Soneira, Marta +4 more
openaire
Invasive meningococcal disease prevention in Spain. Adult meningococcal vaccination
Vacunas (English Edition), 2019F.A. Moraga-Llop, M. Campins Martí
openaire +1 more source
Be vigilant for invasive meningococcal disease.
The Practitioner, 2014Neisseria meningitidis is an encapsulated Gram-negative diplococcus which colonises the upper respiratory tract without causing symptoms in up to 25% of the population. At least 13 different serogroups cause invasive meningococcal disease (IND). In the UK serogroup B causes more than 80% of cases of invasive disease. More than 75% of cases occur in the
openaire +1 more source
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2020Aaron J Grossberg +2 more
exaly
Oral complications of cancer and cancer therapy
Ca-A Cancer Journal for Clinicians, 2012Joel B Epstein +2 more
exaly
Invasive meningococcal disease in Spain, 2024
Introducción: La enfermedad meningocócica invasiva (EMI) es una enfermedad infecciosa grave de declaración obligatoria. El objetivo es describir la epidemiología de la EMI en España en el año 2024 y compararla con años anteriores. Método: Análisis epidemiológico descriptivo de los casos de EMI notificados a la Red Nacional de Vigilancia Epidemiológica (Masa Calles, Josefa +5 more
openaire
Invasive meningococcal disease presenting with cellulitis
Medical Journal of Australia, 2006Karina J Kennedy +2 more
openaire +1 more source